Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.31092877.v1Figure 3. Sustained astrocyte hM3Dq signaling reduces Aβ plaque load in astro-hM3Dq;AppNL-F mice. (A) Experimental timeline for astrohM3Dq and astro-hM3Dq;AppNL-F mice receiving vehicle or CNO (1mg/kg, i.p.) for 6weeks. (B–E) Representative immunostaining images (10×) showing Aβ in AppNL-F mice treated with vehicle (B) or CNO (C), and astro-hM3Dq;AppNL-F mice treated with vehicle (D) or CNO (E). (F–I) Representative cortical immunostaining images (40×) showing Aβ in AppNL-F mice receiving vehicle (F), or CNO (G), and astro-hM3Dq;AppNL-F mice receiving vehicle (H), or CNO (I). (J–M) Representative hippocampal immunostaining images (40×) showing Aβ in AppNL-F mice receiving vehicle (J), or CNO (K), and astro-hM3Dq;AppNL-F mice receiving vehicle (L), or CNO (M). (N–P) Quantification of cortical amyloid pathology including Aβ+ area (N), mean plaque size (O), and plaque number normalized to the imaged area (P). (Q–S) Quantification of hippocampal amyloid pathology including Aβ+ area (Q), mean plaque size (R), and plaque number normalized to the imaged area (S).
Keyword(s):
Astrocytes; Neurosciences not elsewhere classified.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)